How can I determine the source of a positive phencyclidine (PCP) result in a urine drug screen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Determining the Source of a Positive PCP Result on Urine Drug Screen

Always obtain confirmatory testing with gas chromatography-mass spectrometry (GC-MS) for any positive PCP immunoassay screen, as false-positives are common and confirmatory tests are highly specific for distinguishing true PCP use from cross-reactivity with medications. 1

Understanding PCP Testing Methodology

  • Screening immunoassays (point-of-care or laboratory-based) are sensitive but susceptible to cross-reactions, resulting in false-positive results that limit their specificity. 1
  • Confirmatory testing using GC-MS can positively identify PCP and is highly unlikely to yield false-positive results. 1, 2
  • Results are classified as either "confirmed" (true positive) or "failed to confirm" (false positive) after GC-MS analysis. 3

Common Causes of False-Positive PCP Screens

Medications with Strong Evidence

Tramadol is the most well-documented cause of false-positive PCP screens, with both tramadol and its active metabolite N-desmethyltramadol confirmed to trigger false-positives through in vitro testing. 3, 4

Dextromethorphan is significantly associated with false-positive PCP results on immunoassay screens. 3

Venlafaxine and desvenlafaxine (Pristiq, Effexor) have been confirmed to cause false-positive PCP results on urine drug screens. 5, 6

Lamotrigine (Lamictal) has been reported to cause false-positive PCP results specifically on Bio-Rad TOX/See urine toxicology screens. 7

Medications with Possible Association

  • Diphenhydramine may cause false-positives, though the association is not statistically significant in all studies. 3
  • Alprazolam, clonazepam, and carvedilol showed statistical association with false-positive PCP screens, but these were also associated with polysubstance abuse, making causation unclear. 3

Clinical Algorithm for Interpretation

Step 1: Obtain Complete Medication History

  • Document all prescription medications, over-the-counter drugs, and supplements the patient is currently taking. 1
  • Specifically inquire about tramadol, dextromethorphan (cough medications), venlafaxine/desvenlafaxine, and lamotrigine use. 3, 4, 5, 6

Step 2: Assess Specimen Validity

  • Check specimen temperature within 4 minutes of collection (should be 90°F-100°F or 32°-38°C). 1
  • Order creatinine concentration with every sample; levels between 2-20 mg/mL indicate dilute specimens that may miss substances present in lower concentrations. 1
  • Document specimen appearance and color to identify potential adulteration or substitution. 1
  • Specimens that are substituted or adulterated should always be considered "positive" and may represent serious substance use disorder requiring specialist referral. 1

Step 3: Order Confirmatory Testing

  • All positive PCP immunoassay screens require GC-MS confirmation to distinguish true positives from false-positives due to medication cross-reactivity. 1, 3, 2
  • If the patient's clinical presentation does not match PCP intoxication and they are taking known interfering medications, strongly suspect a false-positive. 7, 6

Step 4: Interpret Results in Clinical Context

  • If GC-MS confirms PCP: True positive indicating actual PCP use. 3
  • If GC-MS fails to confirm: False-positive likely due to medication cross-reactivity. 3, 4
  • PCP has unpredictable excretion patterns and can result in negative urines followed by positive urines without further ingestion due to redistribution from tissue stores. 8

Critical Pitfalls to Avoid

  • Never make clinical decisions based solely on immunoassay screening results without confirmatory testing, as cross-reactivity is common. 1
  • Do not dismiss the possibility of false-positives even when the patient denies medication use—obtain comprehensive medication history including recent medication changes. 1
  • Be aware that different immunoassay platforms may have different cross-reactivity profiles (e.g., lamotrigine specifically affects Bio-Rad TOX/See screens). 7
  • Remember that timing matters: PCP may not be detected in blood or urine if present only in nanogram/mL amounts, requiring sensitive methods for detection. 8

When Confirmatory Testing is Not Immediately Available

  • Seek assistance from the testing laboratory when results do not correlate with clinical findings. 1
  • Consider repeat testing if substance use disorder is highly suspected clinically despite negative or questionable results. 1
  • Document all interfering medications in the medical record to provide context for interpretation. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.